Clinical Trial Update: Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Shugan Jieyu Capsule for Generalized Anxiety Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Shugan Jieyu Capsule

Snippet

Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd. | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: RECRUITING